Product Code: ETC6188863 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The porcine vaccine market in Australia is growing due to increasing focus on animal health and disease prevention in the swine industry. Porcine vaccines protect pigs against diseases such as porcine reproductive and respiratory syndrome (PRRS) and swine fever. Rising demand for pork and government support for animal health programs are driving market growth.
The porcine vaccine market in Australia is driven by increasing demand for effective disease prevention and livestock health management. The rise in pig farming and growing concerns about animal health and food safety are encouraging the adoption of porcine vaccines. Government initiatives promoting animal health, advancements in vaccine technology, and the increasing prevalence of diseases such as porcine reproductive and respiratory syndrome (PRRS) are contributing to market growth.
The porcine vaccine market in Australia faces challenges from strict veterinary regulations and high costs of vaccine development. Limited availability of skilled veterinary professionals and infrastructure for administering vaccines restricts market growth. The presence of counterfeit vaccines and inconsistent cold chain logistics further complicate distribution. Regulatory barriers for the approval of new vaccines add to operational costs.
The Australia Porcine Vaccine Market offers significant growth potential due to increasing focus on animal health and disease prevention in the swine industry. Investment opportunities include developing multivalent and recombinant vaccines, improving cold chain logistics, and expanding into swine farming cooperatives and veterinary clinics. Investing in advanced delivery systems such as oral and intranasal vaccines can enhance market penetration.
The porcine vaccine market is regulated under the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the Department of Agriculture, Fisheries, and Forestry (DAFF). The government supports research into new porcine vaccines for disease prevention and herd health management. Import regulations ensure that imported vaccines meet efficacy and safety standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Porcine Vaccine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Porcine Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Porcine Vaccine Market - Industry Life Cycle |
3.4 Australia Porcine Vaccine Market - Porter's Five Forces |
3.5 Australia Porcine Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.6 Australia Porcine Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Australia Porcine Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Australia Porcine Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Porcine Vaccine Market Trends |
6 Australia Porcine Vaccine Market, By Types |
6.1 Australia Porcine Vaccine Market, By Disease Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Porcine Vaccine Market Revenues & Volume, By Disease Indication, 2021- 2031F |
6.1.3 Australia Porcine Vaccine Market Revenues & Volume, By Diarrhea, 2021- 2031F |
6.1.4 Australia Porcine Vaccine Market Revenues & Volume, By Swine Influenza, 2021- 2031F |
6.1.5 Australia Porcine Vaccine Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.1.6 Australia Porcine Vaccine Market Revenues & Volume, By Bordatella Rhinitis, 2021- 2031F |
6.1.7 Australia Porcine Vaccine Market Revenues & Volume, By Porcine Reproductive and Respiratory Virus (PRRSV), 2021- 2031F |
6.1.8 Australia Porcine Vaccine Market Revenues & Volume, By Porcine Circovirus Associated Disease (PCVAD), 2021- 2031F |
6.2 Australia Porcine Vaccine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Australia Porcine Vaccine Market Revenues & Volume, By Veterinary Hospitals, 2021- 2031F |
6.2.3 Australia Porcine Vaccine Market Revenues & Volume, By Hog/Pig Production Farms, 2021- 2031F |
6.3 Australia Porcine Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Porcine Vaccine Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.3.3 Australia Porcine Vaccine Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.3.4 Australia Porcine Vaccine Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.3.5 Australia Porcine Vaccine Market Revenues & Volume, By Recombinant Vaccines, 2021- 2031F |
6.3.6 Australia Porcine Vaccine Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.3.7 Australia Porcine Vaccine Market Revenues & Volume, By DNA Vaccines, 2021- 2031F |
7 Australia Porcine Vaccine Market Import-Export Trade Statistics |
7.1 Australia Porcine Vaccine Market Export to Major Countries |
7.2 Australia Porcine Vaccine Market Imports from Major Countries |
8 Australia Porcine Vaccine Market Key Performance Indicators |
9 Australia Porcine Vaccine Market - Opportunity Assessment |
9.1 Australia Porcine Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.2 Australia Porcine Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Australia Porcine Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Australia Porcine Vaccine Market - Competitive Landscape |
10.1 Australia Porcine Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Australia Porcine Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |